TipRanks
Crispr Therapeutics AG (MX:CRSPN)
:CRSPN
Mexico Market
CRSPN
Crispr Therapeutics AG
RESEARCH TOOLSreports

Crispr Therapeutics AG (CRSPN) Income Statement

0 Followers

Crispr Therapeutics AG Income Statement

Last quarter (Q2 2026), Crispr Therapeutics AG's total revenue was $10.18M, an increase of 1041.37% from the same quarter last year. In Q2, Crispr Therapeutics AG's net income was $-91.15M. See Crispr Therapeutics AG’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 3.51M$ 35.00M$ 370.00M$ 436.00K$ 913.08M
Gross Profit
$ -229.45M$ -75.25M$ 239.75M$ -109.81M$ 811.90M
Operating Expenses
$ 338.87M$ 391.32M$ 462.29M$ 563.35M$ 438.38M
Depreciation and Amortization
$ 19.48M$ 19.26M$ 19.84M$ 24.17M$ 17.95M
EBITDA
$ -558.49M$ -343.41M$ -130.88M$ -626.33M$ 397.48M
Operating Income
$ -568.32M$ -466.57M$ -222.54M$ -673.16M$ 373.53M
Other Income/Expenses
$ -9.65M$ 103.90M$ 71.82M$ 22.66M$ 6.00M
Pretax Income
$ -577.97M$ -362.67M$ -150.72M$ -650.50M$ 379.53M
Net Income
$ -581.60M$ -366.25M$ -153.61M$ -650.17M$ 377.66M
Per Share Metrics
Basic EPS
$ -6.47$ -4.34$ -1.94$ -8.36$ 4.97
Diluted EPS
$ -6.47$ -4.34$ -1.94$ -8.36$ 4.70
Weighted Average Shares Outstanding
 89.93M 84.36M 79.22M 77.75M 75.95M
Weighted Average Shares Outstanding (Diluted)
 89.93M 84.36M 79.22M 77.75M 80.39M
Currency in USD

Crispr Therapeutics AG Earnings and Revenue History